ATE293160T1 - Nicht-embryonale ependymale neuronale stammzellen und methoden zu ihrer isolierung - Google Patents

Nicht-embryonale ependymale neuronale stammzellen und methoden zu ihrer isolierung

Info

Publication number
ATE293160T1
ATE293160T1 AT99933396T AT99933396T ATE293160T1 AT E293160 T1 ATE293160 T1 AT E293160T1 AT 99933396 T AT99933396 T AT 99933396T AT 99933396 T AT99933396 T AT 99933396T AT E293160 T1 ATE293160 T1 AT E293160T1
Authority
AT
Austria
Prior art keywords
ependymal
stem cells
notch
embryonal
isolation
Prior art date
Application number
AT99933396T
Other languages
English (en)
Inventor
Ann Marie Janson
Jonas Frisen
Clas Johansson
Stefan Momma
Diana Clarke
Ming Zhao
Urban Lendahl
Kioumars Delfani
Original Assignee
Neuronova Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neuronova Ab filed Critical Neuronova Ab
Application granted granted Critical
Publication of ATE293160T1 publication Critical patent/ATE293160T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0618—Cells of the nervous system
    • C12N5/0623—Stem cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • C12N5/12—Fused cells, e.g. hybridomas
    • C12N5/16—Animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Neurology (AREA)
  • Genetics & Genomics (AREA)
  • Neurosurgery (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Urology & Nephrology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Cardiology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Vascular Medicine (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Ophthalmology & Optometry (AREA)
  • Psychiatry (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT99933396T 1998-06-25 1999-06-24 Nicht-embryonale ependymale neuronale stammzellen und methoden zu ihrer isolierung ATE293160T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9802264A SE9802264D0 (sv) 1998-06-25 1998-06-25 A method of isolating cells
PCT/SE1999/001157 WO1999067363A1 (en) 1998-06-25 1999-06-24 Ependymal neural stem cells and method for their isolation

Publications (1)

Publication Number Publication Date
ATE293160T1 true ATE293160T1 (de) 2005-04-15

Family

ID=20411839

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99933396T ATE293160T1 (de) 1998-06-25 1999-06-24 Nicht-embryonale ependymale neuronale stammzellen und methoden zu ihrer isolierung

Country Status (14)

Country Link
US (1) US7320872B2 (de)
EP (1) EP1090105B1 (de)
JP (1) JP2002518043A (de)
KR (1) KR20010071601A (de)
CN (1) CN1325637C (de)
AT (1) ATE293160T1 (de)
AU (1) AU770501B2 (de)
BR (1) BR9911509A (de)
CA (1) CA2330175A1 (de)
DE (1) DE69924728T2 (de)
ES (1) ES2241297T3 (de)
MX (1) MXPA00012078A (de)
SE (1) SE9802264D0 (de)
WO (1) WO1999067363A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6541247B1 (en) * 1998-06-25 2003-04-01 Neuronova Ab Method of isolating ependymal neural stem cells
DE60123937T2 (de) * 2000-04-13 2007-06-14 The Board of Regents, The University of Texas System, Austin Behandlung von neuro-degenerativen gastrointestinalkrankheiten durch impantation von neuronalen stammzellen und/oder deren nachkommen in gastrointestinalorgane
GB0013260D0 (en) * 2000-05-31 2000-07-19 Neuronova Ab Method
AU2002307455A1 (en) * 2001-04-20 2002-11-05 Memorial Sloan-Kettering Cancer Center Generation of differentiated tissue from nuclear transfer embryonic stem cells and methods of use
AU2003265094A1 (en) * 2002-08-26 2004-03-11 Neuronova Ab Method for culturing stem cells
EP1827108B1 (de) * 2004-11-29 2015-04-08 Yeda Research And Development Co., Ltd. Induktion der neurogenese und stammzellentherapie in kombination mit copolymer 1
US20100015615A1 (en) * 2008-04-30 2010-01-21 Sloan-Kettering Institute For Cancer Research Identification and Isolation of Adult Stem Cells and Related Methods of Use
US8962314B2 (en) 2008-11-26 2015-02-24 The Regents Of The University Of California Lateral ventricle cell compositions and use for treating neural degenerative diseases
AU2010276201B2 (en) * 2009-07-21 2013-10-17 Abt Holding Company Use of stem cells to reduce leukocyte extravasation
ES2402308B2 (es) * 2011-09-27 2013-12-27 Universidad De Málaga Procedimiento de obtención de un cultivo puro de células ependimarias multiciliadas.
WO2019165306A1 (en) * 2018-02-23 2019-08-29 Regeneration Biomedical, Inc. Methods, apparatuses and systems for instilling stem cells and pharmaceuticals into the human ventricular system
CN111440768B (zh) * 2020-04-23 2022-09-02 青岛海尔生物科技有限公司 重组人Notch1蛋白在制备神经干细胞及皮层神经元中的应用
CN113777296A (zh) * 2021-09-16 2021-12-10 复旦大学附属中山医院 一种全量组织免疫荧光方法和应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5851832A (en) 1991-07-08 1998-12-22 Neurospheres, Ltd. In vitro growth and proliferation of multipotent neural stem cells and their progeny
EP0658194A1 (de) * 1992-07-27 1995-06-21 California Institute Of Technology Multipotenten neuronalen säugetierstammzellen
DK0728194T3 (da) * 1993-11-09 2003-04-22 Neurospheres Holdings Ltd In situ modifikation og manipulation af stamceller fra centralnervesystemet.
CN1161744A (zh) * 1994-09-23 1997-10-08 纽罗斯菲里斯控股有限公司 中枢神经系统(cns)功能和机能障碍的体外模型
US5753505A (en) * 1995-07-06 1998-05-19 Emory University Neuronal progenitor cells and uses thereof
US5800812A (en) 1995-09-15 1998-09-01 Yeda Research And Development Co. Ltd. Methods of use of mononuclear phagocytes to promote axonal regeneration
US5780300A (en) * 1995-09-29 1998-07-14 Yale University Manipulation of non-terminally differentiated cells using the notch pathway
US5753506A (en) * 1996-05-23 1998-05-19 Cns Stem Cell Technology, Inc. Isolation propagation and directed differentiation of stem cells from embryonic and adult central nervous system of mammals
US6093531A (en) * 1997-09-29 2000-07-25 Neurospheres Holdings Ltd. Generation of hematopoietic cells from multipotent neural stem cells
US6541247B1 (en) 1998-06-25 2003-04-01 Neuronova Ab Method of isolating ependymal neural stem cells

Also Published As

Publication number Publication date
MXPA00012078A (es) 2005-06-20
KR20010071601A (ko) 2001-07-28
BR9911509A (pt) 2001-03-20
CA2330175A1 (en) 1999-12-29
EP1090105A1 (de) 2001-04-11
AU4945999A (en) 2000-01-10
DE69924728T2 (de) 2006-03-09
SE9802264D0 (sv) 1998-06-25
WO1999067363A9 (en) 2000-03-16
EP1090105B1 (de) 2005-04-13
WO1999067363A1 (en) 1999-12-29
CN1325637C (zh) 2007-07-11
AU770501B2 (en) 2004-02-26
US7320872B2 (en) 2008-01-22
ES2241297T3 (es) 2005-10-16
US20030092176A1 (en) 2003-05-15
DE69924728D1 (de) 2005-05-19
CN1307632A (zh) 2001-08-08
JP2002518043A (ja) 2002-06-25

Similar Documents

Publication Publication Date Title
ATE293160T1 (de) Nicht-embryonale ependymale neuronale stammzellen und methoden zu ihrer isolierung
CA2262920A1 (en) Method for identifying compounds affecting rna/rna binding protein interactions
CY1111006T1 (el) Εκριμματαση ασθενειας alzheimer
EP1131333A4 (de) Isolierte nukleinsäuremoleküle die t-zellen induzierbare faktoren kodieren (tif), kodierte proteine und ihre anwendung
WO1997030024A3 (de) Lipidverbindungen und deren verwendung z.b. in liposomen
DE69942459D1 (de) Isolierte nukleinsäuremoleküle die t-zellen induzierbare faktoren kodieren (tif), kodierte proteine und ihre anwendung
HUP9802538A2 (hu) Vektorok és eljárások helyspecifikus rekombináció előidézésére
Stringer Human evolution and biological adaptation in the Pleistocene.
WO2002002783A3 (en) Expression vectors
DE69611778D1 (de) Separator für feststoffpolyelektrolytbrennstoffzellen und dessen herstellung
WO1999045098A3 (en) Delivery or proteins into eukaryotic cells with recombinant yersinia
BR9912455A (pt) ácidos nucléicos codificadores de proteìnas envolvidas em transdução sensória
WO2001004282A3 (en) Replication-competent anti-cancer vectors
WO2000009677A3 (en) Sterol-regulated site-1 protease and assays of modulators thereof
AU2236795A (en) Afamin: a human serum albumin-like protein
FR2755144B1 (fr) Fragments d'anticorps a chaine unique anti-p53 et utilisation
EP0899541A3 (de) Apparat zur Bestimmung der Dicke eines optischen Prüfkörpers
EP1342729A3 (de) Antikörper und Antisensmoleküle für G-gekoppeltes Rezeptor mit selektiver Affinität für ATP
DE59707813D1 (de) Rezeptorbindungsassay, für den rezeptorbindungsassay geeigneter rekombinanter fusionsrezeptor, vektor zu dessen herstellung sowie reagenziensatz für die durchführung des rezeptorbindungsassays
FR2778670B1 (fr) Methodes et compositions pour la production de particules virales
WO2002094992A3 (en) Directed evolution of protein in mammalian cells
CA2146240A1 (en) Increased production of secreted proteins by recombinant eukaryotic cells
BR9814255A (pt) Partìculas de transfecção
WO2001019860A3 (en) Proteins associated with cell differentiation
WO2000039154A3 (de) Peptide des at1-rezeptors und ihre verwendung bei präeklampsie und maligner hypertonie

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1090105

Country of ref document: EP